1 / 13

Introduction

IMPACT ON THE USE AND COST OF MEDICINES OF EXPANDED DRUG COVERAGE VIA A POSITIVE LIST IN THE PHILIPPINES: A LONGITUDINAL STUDY. Acuin J for the QARPDG Group (Valera M, Acuin J, Soria F, Lavina S, Barbosa J, Bacting M, Palafox B). Introduction.

herbst
Download Presentation

Introduction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IMPACT ON THE USE AND COST OF MEDICINES OF EXPANDED DRUG COVERAGE VIA A POSITIVE LIST IN THE PHILIPPINES: A LONGITUDINAL STUDY Acuin J for the QARPDG Group (Valera M, Acuin J, Soria F, Lavina S, Barbosa J, Bacting M, Palafox B)

  2. Introduction • The National Health Insurance program covers mainly inpatient care up to pre-set limits for each of the following components: • drugs, supplies, surgical procedures, room and board • Drug prescriptionsconstitute the largest proportion (32% of the total benefit payments) • The expansion of the list of reimbursable drugs through the implementation of the Positive List was aimed at increasing choice and improving adherence to practice guidelines

  3. General Objective To determine the impact of expanded drug coverage (Positive List) implemented by the Philippine Health Insurance Corporation on prescribing patterns of physicians and medication costs among adult patients diagnosed with pneumonia admitted in PHIC accredited hospitals before and after its implementation in October 2000.

  4. Methods • A time series design • consisting of 12 monthly time points immediately before and after a 3-month implementation period of the Positive List • 18 PHIC-accredited tertiary hospitals randomly selected from three major urban centers in the Philippines

  5. Methods • Main outcomes • Monthly average percentage antibiotic prescriptions (total, national formulary and positive list antibiotic prescriptions) • Monthly average total drug costs per hospitalization • Monthly average percentage of appropriate antibiotic types • PHIC vs non-PHIC members • Rolling 3 month averages

  6. RESULTS

  7. Positive List Implementation

  8. Monthly percent cefuroxime prescriptions unchanged government private Positive list implementation Positive List Implementation

  9. Conclusions • The Positive List expanded physicians’ choice. • We found no effect on prescribing patterns and drug costs. • We found an increasing trend in the use of appropriate antibiotic types unrelated to the Positive List.

  10. Implications • Suggests weak policy dissemination and resistant inappropriate practice patterns among largely unregulated “free agents” • May confirm lack of effectiveness of single interventions, including financial incentives

  11. Implications • Impact of discrete strategies on whole policy environment controlling access to drugs • Positive list strategy may be a low risk policy lever • Multiple interventions targeting both institutions and individual drug prescribers but also overall drug supply and demand

More Related